Through the USAID Qualifying, Testing, Issuing (QTI) project, FHI 360 implements a comprehensive quality assurance program using a strategic, risk-based approach to ensure that health commodities procured on behalf of USAID are safe, effective, and of acceptable quality for clients and patients. The project includes:
- Conducting product risk assessments.
- Qualifying vendors of health commodities.
- Performing audits and evaluations of vendors.
- Managing vendor and product eligibility lists.
- Managing product quality incidents and recalls.
- Conducting quality control sampling, testing and analysis.
Through these quality assurance and quality control objectives, FHI 360 ensures that USAID’s supply chain has access to quality-assured health products (including pharmaceuticals, medical devices, in vitro diagnostics and vector control commodities) that support USAID’s health responses to HIV, family planning, maternal and child health and nutrition, malaria, other infectious diseases and emerging pandemic threats, and more.
QTI is part of USAID’s Next Generation (NextGen) Supply Chain Suite of Programs.